Spinout Successes

University of Edinburgh Spinouts include:

Actinogen

Actinogen is an Australian Stock Exchange listed company developing UE2343 for Alzheimer’s disease.

www.actinogen.com

Aquila BioMedical

Aquila BioMedical provides specialist in vitro and in vivo drug profiling services to the pharma/biotech industries. It is increasingly focused on the provision of in vitro models for the assessment of immune-modulating drugs and biologics.

www.aquila-bm.com

Edinburgh Molecular Imaging

EM Imaging is developing a range of diagnostic ‘probes’ for the rapid detection of respiratory disease and colorectal cancer.

www.edinimage.com

NeurocentRx Pharma Ltd

NeurocentRx is a specialty pharma company focusing on cancer-related pain and the palliative/supportive care market.

www.neurocentrx.com

Triscribe

Triscribe is a start-up company developing potential hospital prescription analysis products for the pharmaceutical industry and other customers.

www.triscribe.net